Pfizer Inc (PFE) 35.27 $PFE
Big Pharma Comes Under Attack From a New Hedge Fund Strategy
Sean Williams, The Motley Fool - Motley Fool - 1 hr 4 mins ago
Source: Teva Pharmaceutical, Facebook. Forget retail short-sellers and angry message board posters, Big Pharma has a much bigger concern on the horizon: hedge funds. I know what you're probably thinking, "Haven't various hedge funds already been...
ACT: 295.41 (-2.95), SHPG: 255.11 (-0.26), PFE: 35.27 (-0.09), JAZZ: 189.42 (+0.33), TEVA: 64.41 (+1.16)
Astra Deals Add To Ballooning Up-Front Payments
EP Vantage - at Seeking Alpha - Sat Apr 25, 7:10AM CDT
The brace of licensing deals unveiled by AstraZeneca (NYSE: AZN ) today are remarkable for their generous up-front payments - but not as remarkable as they might once have been. An analysis of the biggest up-front outlays of the past 10 years shows...
PFE: 35.27 (-0.09), AZN: 71.79 (-1.34), ABBV: 66.07 (+1.82)
Are Biosimilars the Next Big Thing in Biotech?
George Budwell, The Motley Fool - Motley Fool - Sat Apr 25, 6:06AM CDT
Biologics, or drugs developed from biological sources, have taken the pharma world by storm over the past decade or so. Five of the top 10 best-selling drugs in 2014, for example, were biologics indicated for either autoimmune disorders or cancer. ...
PFE: 35.27 (-0.09), MRK: 57.60 (+0.09), AMGN: 167.91 (-1.26), TEVA: 64.41 (+1.16), ABBV: 66.07 (+1.82), NVS: 104.28 (-1.22)
Most active New York Stock Exchange-traded stocks
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
GE: 26.80 (-0.05), AA: 13.22 (+0.03), CLV: 5.91 (+0.43), PFE: 35.27 (-0.09), GM: 35.59 (-0.33), XRX: 11.99 (-1.15), CLF: 6.03 (+0.47), BAC: 15.64 (-0.05), MCP: 0.99 (+0.15)
Final Glance: Pharmaceuticals companies
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)
Stocks rise on tech earnings; Nasdaq adds to record
By KEN SWEET - AP - Fri Apr 24, 3:28PM CDT
NEW YORK (AP) — Stocks advanced slightly Friday as investors cheered the quarterly results of three large technology companies: Google, Microsoft and Amazon.
AMZN: 445.10 (+55.11), PFE: 35.27 (-0.09), GOOGL: 573.66 (+16.20), CMCSK: 59.19 (+0.50), GOOG: 565.06 (+18.06), CMCSA: 59.64 (+0.41)
Seeking Alpha's Biotech Weekly: Gilead Isn't Perfect, Biogen-Bass, Spring Fever, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors grappled with deals real and imagined, industry competition...
BIIB: 401.71 (-28.57), VRTX: 133.20 (-2.62), PRGO: 192.89 (-8.74), PFE: 35.27 (-0.09), CLDN: 13.68 (-0.26), MYL: 76.06 (+2.37), OREX: 7.36 (-0.08), JNJ: 101.08 (+0.62), NVO: 56.65 (+0.44), TNXP: 6.52 (-0.15), ALNY: 119.01 (+0.29), GILD: 103.69 (-1.52), SGEN: 37.14 (-0.36), ACHN: 10.06 (+0.06), MRK: 57.60 (+0.09), GALE: 1.45 (+0.02), JUNO: 56.66 (-1.06), SNY: 51.75 (-0.01), NBY: 0.63 (unch), XLRN: 33.29 (-0.95)
Dogs Of The Dow March Quarter Roundup
Value Line - Seeking Alpha - Fri Apr 24, 3:00PM CDT
By Mario Ferro Failing To Get Traction The bulls would like to extend the Dow's winning streak to a seventh consecutive year, but the going has been considerably tougher of late. To wit, a balanced investment in the stocks that make up the Dow...
AMT: 95.32 (-0.72), PFE: 35.27 (-0.09), DIA: 180.54 (+0.17), MCD: 98.74 (+1.74), CAT: 84.60 (-0.19), HSP: 87.61 (-0.05)
Nurturing Your Portfolio With Mead Johnson
DividendDeveloper - Seeking Alpha - Fri Apr 24, 2:45PM CDT
Quick Background : Mead Johnson Nutrition (NYSE: MJN ) is a global pediatric nutrition company. The company's brands include the flagship Enfa family (including the well-known Enfamil), Nutramigen, Cal-C-Tose, and ChocoMilk. The company was founded...
ABT: 48.32 (-0.14), MJN: 97.94 (+1.53), PFE: 35.27 (-0.09)
The Parade of Weak Earnings Reports Continues - Earnings Preview
Sheraz Mian - ZACKS - Fri Apr 24, 2:39PM CDT
The Parade of Weak Earnings Reports Continues - Earnings Preview
ACT: 295.41 (-2.95), F: 15.77 (+0.01), ETN: 68.58 (-0.52), PFE: 35.27 (-0.09), IP: 53.67 (+0.79), COP: 67.51 (-0.75), XOM: 86.97 (-0.57), BAC: 15.64 (-0.05), UPS: 98.10 (-0.12), GILD: 103.69 (-1.52), MRK: 57.60 (+0.09), CVS: 101.58 (+0.70), CVX: 109.87 (-0.10), AAPL: 130.28 (+0.61), VIAB: 70.74 (+0.04), MA: 90.72 (-0.16)
'Non-Cyclical Consumer Healthcare': How This Sector Will Create Long-Term Wealth
Peter Mantas - Seeking Alpha - Fri Apr 24, 1:39PM CDT
Allow me to provide you with a hypothetical portfolio containing only 5 stocks. This portfolio is somewhat diversified in that each company operates in different markets with different threats, competitors and opportunities, but all 5 companies have...
MCK: 229.20 (+0.09), AKRX: 55.24 (-0.68), PFE: 35.27 (-0.09), EW: 138.33 (-3.59), LLY: 71.58 (-0.82), GSK: 46.59 (+0.28), MOH: 63.85 (-0.13), ORCL: 43.08 (-0.31), CNC: 73.67 (+1.13), JNJ: 101.08 (+0.62), ANTM: 154.28 (+0.08), VRSK: 72.68 (+0.20), GILD: 103.69 (-1.52), RMD: 65.70 (-7.68), MRK: 57.60 (+0.09), AZN: 71.79 (-1.34), FICO: 93.85 (+0.55), WCN: 46.52 (+0.32), SRCL: 136.94 (-3.56), SNY: 51.75 (-0.01), ACN: 93.40 (-0.44), NVS: 104.28 (-1.22)
Midday Glance: Pharmaceuticals companies
AP - Fri Apr 24, 12:36PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)
Business events scheduled for the coming week
By The Associated Press - AP - Fri Apr 24, 12:28PM CDT
All times are Eastern.
GT: 27.74 (unch), F: 15.77 (+0.01), V: 67.48 (-0.24), PFE: 35.27 (-0.09), MRK: 57.60 (+0.09), CVS: 101.58 (+0.70), XOM: 86.97 (-0.57), BRK.B: 142.09 (-0.34), TWTR: 50.82 (-0.59), BRK.A: 214,490.00 (-250.00), AET: 108.82 (-0.08), AAPL: 130.28 (+0.61)
Early Glance: Pharmaceuticals companies
AP - Fri Apr 24, 9:55AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)
Nasdaq Takes Lead In Mixed Open; Microsoft Surges, Biogen Dives
at Investor's Business Daily - Fri Apr 24, 9:35AM CDT
Tech stocks took early control Friday, as the market posted a mixed launch in solid trade. The Nasdaq jumped 0.5%, climbing well into new territory above its 15-year high. The Dow Jones industrial average slipped 0.1%. The S&P 500 added 0.1%, leaving...
BIIB: 401.71 (-28.57), NOAH: 33.79 (+0.63), MMM: 158.99 (-0.67), AMZN: 445.10 (+55.11), NKE: 100.95 (-0.16), AKRX: 55.24 (-0.68), PFE: 35.27 (-0.09), BA: 148.40 (-1.47), MSFT: 47.87 (+4.53)
Scuttled mining combo tops list of biggest failed deals
By The Associated Press - AP - Fri Apr 24, 9:24AM CDT
Comcast's failed $45 billion deal for Time Warner Cable is a high-profile example of a failed deal, but it doesn't crack the list of the 10 largest.
TI.A: 9.45 (-0.01), TI: 11.77 (+0.03), PFE: 35.27 (-0.09), DIS: 109.53 (+0.53), CMCSK: 59.19 (+0.50), TWX: 85.36 (+0.48), FOX: 33.96 (+0.31), S: 5.27 (+0.03), FOXA: 34.65 (+0.30), TWC: 155.26 (+6.50), CMCSA: 59.64 (+0.41)
Next Week In Biotech: Gilead, Celgene Report; PDUFAs For Theravance, The Medicines Co.
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 8:00AM CDT
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
VRX: 210.42 (+1.03), BMRN: 120.28 (-2.67), UTHR: 186.69 (-1.87), CLDX: 30.10 (+0.19), ACOR: 33.12 (-0.38), AFFX: 12.44 (-0.16), HSP: 87.61 (-0.05), OXGN: 1.48 (unch), MACK: 13.42 (-0.25), HBIO: 6.22 (+0.08), ECYT: 6.17 (-0.13), GEVA: 108.51 (+0.92), CYTR: 5.13 (-0.13), THRX: 17.92 (+0.46), FF: 11.18 (+0.03), MDXG: 9.81 (-0.39), EXEL: 3.08 (-0.02), VRTX: 133.20 (-2.62), NEO: 4.75 (-0.11), PFE: 35.27 (-0.09), INCY: 107.34 (-0.51), MYL: 76.06 (+2.37), AMGN: 167.91 (-1.26), ANIK: 38.35 (-0.32), ALKS: 62.26 (-1.19), ONTY: 1.74 (-0.05), CELG: 118.71 (+2.62), NBIX: 43.37 (-0.31), SGEN: 37.14 (-0.36), OGXI: 2.19 (+0.04), EBIO: 11.19 (+0.69), ABAX: 63.62 (+0.31), GILD: 103.69 (-1.52), GERN: 4.30 (-0.03), HAE: 43.35 (+0.74), MRK: 57.60 (+0.09), TEVA: 64.41 (+1.16), PCRX: 85.07 (+0.80)
Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer
M2 - Fri Apr 24, 4:33AM CDT
Pfizer Inc. announced today that XALKORI® (crizotinib) received Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the potential treatment of patients with ROS1-positive non-small cell lung cancer (NSCLC). Occurring in approximately one percent of NSCLC cases1, ROS1-positive NSCLC represents a particular molecular subgroup of NSCLC.2 XALKORI currently is approved in the U.S. for the treatment of patients with metastatic NSCLC whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
PFE: 35.27 (-0.09)
Big Pharma Comes Under Attack From a New Hedge Fund Strategy
Sean Williams, The Motley Fool - Motley Fool - 1 hr 4 mins ago
Source: Teva Pharmaceutical, Facebook. Forget retail short-sellers and angry message board posters, Big Pharma has a much bigger concern on the horizon: hedge funds. I know what you're probably thinking, "Haven't various hedge funds already been...
ACT: 295.41 (-2.95), SHPG: 255.11 (-0.26), PFE: 35.27 (-0.09), JAZZ: 189.42 (+0.33), TEVA: 64.41 (+1.16)
Astra Deals Add To Ballooning Up-Front Payments
EP Vantage - at Seeking Alpha - Sat Apr 25, 7:10AM CDT
The brace of licensing deals unveiled by AstraZeneca (NYSE: AZN ) today are remarkable for their generous up-front payments - but not as remarkable as they might once have been. An analysis of the biggest up-front outlays of the past 10 years shows...
PFE: 35.27 (-0.09), AZN: 71.79 (-1.34), ABBV: 66.07 (+1.82)
Are Biosimilars the Next Big Thing in Biotech?
George Budwell, The Motley Fool - Motley Fool - Sat Apr 25, 6:06AM CDT
Biologics, or drugs developed from biological sources, have taken the pharma world by storm over the past decade or so. Five of the top 10 best-selling drugs in 2014, for example, were biologics indicated for either autoimmune disorders or cancer. ...
PFE: 35.27 (-0.09), MRK: 57.60 (+0.09), AMGN: 167.91 (-1.26), TEVA: 64.41 (+1.16), ABBV: 66.07 (+1.82), NVS: 104.28 (-1.22)
Most active New York Stock Exchange-traded stocks
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
GE: 26.80 (-0.05), AA: 13.22 (+0.03), CLV: 5.91 (+0.43), PFE: 35.27 (-0.09), GM: 35.59 (-0.33), XRX: 11.99 (-1.15), CLF: 6.03 (+0.47), BAC: 15.64 (-0.05), MCP: 0.99 (+0.15)
Final Glance: Pharmaceuticals companies
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)
Stocks rise on tech earnings; Nasdaq adds to record
By KEN SWEET - AP - Fri Apr 24, 3:28PM CDT
NEW YORK (AP) — Stocks advanced slightly Friday as investors cheered the quarterly results of three large technology companies: Google, Microsoft and Amazon.
AMZN: 445.10 (+55.11), PFE: 35.27 (-0.09), GOOGL: 573.66 (+16.20), CMCSK: 59.19 (+0.50), GOOG: 565.06 (+18.06), CMCSA: 59.64 (+0.41)
Seeking Alpha's Biotech Weekly: Gilead Isn't Perfect, Biogen-Bass, Spring Fever, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 3:00PM CDT
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. This week, contributors grappled with deals real and imagined, industry competition...
BIIB: 401.71 (-28.57), VRTX: 133.20 (-2.62), PRGO: 192.89 (-8.74), PFE: 35.27 (-0.09), CLDN: 13.68 (-0.26), MYL: 76.06 (+2.37), OREX: 7.36 (-0.08), JNJ: 101.08 (+0.62), NVO: 56.65 (+0.44), TNXP: 6.52 (-0.15), ALNY: 119.01 (+0.29), GILD: 103.69 (-1.52), SGEN: 37.14 (-0.36), ACHN: 10.06 (+0.06), MRK: 57.60 (+0.09), GALE: 1.45 (+0.02), JUNO: 56.66 (-1.06), SNY: 51.75 (-0.01), NBY: 0.63 (unch), XLRN: 33.29 (-0.95)
Dogs Of The Dow March Quarter Roundup
Value Line - Seeking Alpha - Fri Apr 24, 3:00PM CDT
By Mario Ferro Failing To Get Traction The bulls would like to extend the Dow's winning streak to a seventh consecutive year, but the going has been considerably tougher of late. To wit, a balanced investment in the stocks that make up the Dow...
AMT: 95.32 (-0.72), PFE: 35.27 (-0.09), DIA: 180.54 (+0.17), MCD: 98.74 (+1.74), CAT: 84.60 (-0.19), HSP: 87.61 (-0.05)
Nurturing Your Portfolio With Mead Johnson
DividendDeveloper - Seeking Alpha - Fri Apr 24, 2:45PM CDT
Quick Background : Mead Johnson Nutrition (NYSE: MJN ) is a global pediatric nutrition company. The company's brands include the flagship Enfa family (including the well-known Enfamil), Nutramigen, Cal-C-Tose, and ChocoMilk. The company was founded...
ABT: 48.32 (-0.14), MJN: 97.94 (+1.53), PFE: 35.27 (-0.09)
The Parade of Weak Earnings Reports Continues - Earnings Preview
Sheraz Mian - ZACKS - Fri Apr 24, 2:39PM CDT
The Parade of Weak Earnings Reports Continues - Earnings Preview
ACT: 295.41 (-2.95), F: 15.77 (+0.01), ETN: 68.58 (-0.52), PFE: 35.27 (-0.09), IP: 53.67 (+0.79), COP: 67.51 (-0.75), XOM: 86.97 (-0.57), BAC: 15.64 (-0.05), UPS: 98.10 (-0.12), GILD: 103.69 (-1.52), MRK: 57.60 (+0.09), CVS: 101.58 (+0.70), CVX: 109.87 (-0.10), AAPL: 130.28 (+0.61), VIAB: 70.74 (+0.04), MA: 90.72 (-0.16)
'Non-Cyclical Consumer Healthcare': How This Sector Will Create Long-Term Wealth
Peter Mantas - Seeking Alpha - Fri Apr 24, 1:39PM CDT
Allow me to provide you with a hypothetical portfolio containing only 5 stocks. This portfolio is somewhat diversified in that each company operates in different markets with different threats, competitors and opportunities, but all 5 companies have...
MCK: 229.20 (+0.09), AKRX: 55.24 (-0.68), PFE: 35.27 (-0.09), EW: 138.33 (-3.59), LLY: 71.58 (-0.82), GSK: 46.59 (+0.28), MOH: 63.85 (-0.13), ORCL: 43.08 (-0.31), CNC: 73.67 (+1.13), JNJ: 101.08 (+0.62), ANTM: 154.28 (+0.08), VRSK: 72.68 (+0.20), GILD: 103.69 (-1.52), RMD: 65.70 (-7.68), MRK: 57.60 (+0.09), AZN: 71.79 (-1.34), FICO: 93.85 (+0.55), WCN: 46.52 (+0.32), SRCL: 136.94 (-3.56), SNY: 51.75 (-0.01), ACN: 93.40 (-0.44), NVS: 104.28 (-1.22)
Midday Glance: Pharmaceuticals companies
AP - Fri Apr 24, 12:36PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)
Business events scheduled for the coming week
By The Associated Press - AP - Fri Apr 24, 12:28PM CDT
All times are Eastern.
GT: 27.74 (unch), F: 15.77 (+0.01), V: 67.48 (-0.24), PFE: 35.27 (-0.09), MRK: 57.60 (+0.09), CVS: 101.58 (+0.70), XOM: 86.97 (-0.57), BRK.B: 142.09 (-0.34), TWTR: 50.82 (-0.59), BRK.A: 214,490.00 (-250.00), AET: 108.82 (-0.08), AAPL: 130.28 (+0.61)
Early Glance: Pharmaceuticals companies
AP - Fri Apr 24, 9:55AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)
Nasdaq Takes Lead In Mixed Open; Microsoft Surges, Biogen Dives
at Investor's Business Daily - Fri Apr 24, 9:35AM CDT
Tech stocks took early control Friday, as the market posted a mixed launch in solid trade. The Nasdaq jumped 0.5%, climbing well into new territory above its 15-year high. The Dow Jones industrial average slipped 0.1%. The S&P 500 added 0.1%, leaving...
BIIB: 401.71 (-28.57), NOAH: 33.79 (+0.63), MMM: 158.99 (-0.67), AMZN: 445.10 (+55.11), NKE: 100.95 (-0.16), AKRX: 55.24 (-0.68), PFE: 35.27 (-0.09), BA: 148.40 (-1.47), MSFT: 47.87 (+4.53)
Scuttled mining combo tops list of biggest failed deals
By The Associated Press - AP - Fri Apr 24, 9:24AM CDT
Comcast's failed $45 billion deal for Time Warner Cable is a high-profile example of a failed deal, but it doesn't crack the list of the 10 largest.
TI.A: 9.45 (-0.01), TI: 11.77 (+0.03), PFE: 35.27 (-0.09), DIS: 109.53 (+0.53), CMCSK: 59.19 (+0.50), TWX: 85.36 (+0.48), FOX: 33.96 (+0.31), S: 5.27 (+0.03), FOXA: 34.65 (+0.30), TWC: 155.26 (+6.50), CMCSA: 59.64 (+0.41)
Next Week In Biotech: Gilead, Celgene Report; PDUFAs For Theravance, The Medicines Co.
SA Editor Mike Taylor - Seeking Alpha - Fri Apr 24, 8:00AM CDT
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
VRX: 210.42 (+1.03), BMRN: 120.28 (-2.67), UTHR: 186.69 (-1.87), CLDX: 30.10 (+0.19), ACOR: 33.12 (-0.38), AFFX: 12.44 (-0.16), HSP: 87.61 (-0.05), OXGN: 1.48 (unch), MACK: 13.42 (-0.25), HBIO: 6.22 (+0.08), ECYT: 6.17 (-0.13), GEVA: 108.51 (+0.92), CYTR: 5.13 (-0.13), THRX: 17.92 (+0.46), FF: 11.18 (+0.03), MDXG: 9.81 (-0.39), EXEL: 3.08 (-0.02), VRTX: 133.20 (-2.62), NEO: 4.75 (-0.11), PFE: 35.27 (-0.09), INCY: 107.34 (-0.51), MYL: 76.06 (+2.37), AMGN: 167.91 (-1.26), ANIK: 38.35 (-0.32), ALKS: 62.26 (-1.19), ONTY: 1.74 (-0.05), CELG: 118.71 (+2.62), NBIX: 43.37 (-0.31), SGEN: 37.14 (-0.36), OGXI: 2.19 (+0.04), EBIO: 11.19 (+0.69), ABAX: 63.62 (+0.31), GILD: 103.69 (-1.52), GERN: 4.30 (-0.03), HAE: 43.35 (+0.74), MRK: 57.60 (+0.09), TEVA: 64.41 (+1.16), PCRX: 85.07 (+0.80)
Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer
M2 - Fri Apr 24, 4:33AM CDT
Pfizer Inc. announced today that XALKORI® (crizotinib) received Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for the potential treatment of patients with ROS1-positive non-small cell lung cancer (NSCLC). Occurring in approximately one percent of NSCLC cases1, ROS1-positive NSCLC represents a particular molecular subgroup of NSCLC.2 XALKORI currently is approved in the U.S. for the treatment of patients with metastatic NSCLC whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.
PFE: 35.27 (-0.09)
